Global incidence and prevalence in uveal melanoma

Xincen Hou; Alexander C. Rokohl; Xueting Li; Yongwei Guo; Xiaojun Ju; Wanlin Fan; Ludwig M. Heindl

doi:10.1016/j.aopr.2024.10.001

您当前的位置：

首页 >

文章列表页 >

Global incidence and prevalence in uveal melanoma

Full Length Article | 更新时间：2024-12-14

- Global incidence and prevalence in uveal melanoma
- Global incidence and prevalence in uveal melanoma
- 眼科实践与研究新进展 2024年4卷第4期页码：226-232
- 作者机构：
  
  1. Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne,Cologne,Germany
  2. Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf,Cologne,Germany
  3. Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,China
- 作者简介：
- 基金信息：
- DOI：10.1016/j.aopr.2024.10.001
  中图分类号：
- 纸质出版日期：2024，
- 稿件说明：
移动端阅览
Xincen Hou, Alexander C. Rokohl, Xueting Li, 等. Global incidence and prevalence in uveal melanoma[J]. 眼科实践与研究新进展, 2024,4(4):226-232.

XINCEN HOU, ALEXANDER C. ROKOHL, XUETING LI, et al. Global incidence and prevalence in uveal melanoma. [J]. Aopr, 2024, 4(4): 226-232.
Xincen Hou, Alexander C. Rokohl, Xueting Li, 等. Global incidence and prevalence in uveal melanoma[J]. 眼科实践与研究新进展, 2024,4(4):226-232. DOI： 10.1016/j.aopr.2024.10.001.

XINCEN HOU, ALEXANDER C. ROKOHL, XUETING LI, et al. Global incidence and prevalence in uveal melanoma. [J]. Aopr, 2024, 4(4): 226-232. DOI： 10.1016/j.aopr.2024.10.001.

摘要

Abstract

PurposeThe most common intraocular cancer in adults is uveal melanoma (UM). This study aimed to investigate and report the incidence and prognosis of UM in different regions of the world.MethodsWe retrieved relevant data on UM from the PubMed database and analyzed its global incidence and prognosis. All data was obtained from a national population-based registry

with publication dates ranging from 2013 to 2023.ResultsThe incidence rates of UM vary across different regions: in the United States

rates were 5.1 per million (1993–2008) and 5.2 per million (1973–2013); in Canada

rates ranged from 3.34 per million (1992–2010) to 5.09 per million (2011–2017); in Republic of Korea

the rate was 0.42 per million (1999–2011); in New Zealand

it was 5.56 per million (2000–2020); in Australia

it was 7.6 per million (1982–2014); and in Europe

rates ranged from 3.1 to 5.8 per million (1995–2002). Among European countries

Sweden (5.6 per million (1960–2009))

Germany (6.41 per million (2009–2015))

Poland (6.67 per million (2010–2017))

and the United Kingdom (10 per million (1999–2010)).ConclusionsThe most common site of occurrence for UM is in the choroid. Limited data suggest a stable trend in UM incidence rates across the included countries

but significant differences in incidence rates exist among different countries and regions

with notably lower rates in Asian countries compared to Europe

North America

and Oceania. In general

the incidence rate in males is slightly higher compared to that in females.

关键词

Keywords

Uveal melanomaIncidenceEpidemiology

references

1 Y. Yonekawa, I.K. KimEpidemiology and management of uveal melanoma Hematol Oncol Clin N Am, 26 (2012), pp. 1169-1184, 10.1016/j.hoc.2012.08.004

2 S. Kashyap, R. Meel, L. Singh, M. SinghUveal melanoma Semin Diagn Pathol, 33 (2016), pp. 141-147, 10.1053/j.semdp.2015.10.005

3 A.D. Singh, M.E. Turell, A.K. TophamUveal melanoma: trends in incidence, treatment, and survival Ophthalmology, 118 (2011), pp. 1881-1885, 10.1016/j.ophtha.2011.01.040

4 M. Vasalaki, I.D. Fabian, M.A. Reddy, V.M. Cohen, M.S. SagooOcular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma Br Med Bull, 121 (2017), pp. 107-119, 10.1093/bmb/ldw053

5 H. Bai, J.J. Bosch, L.M. HeindlCurrent management of uveal melanoma: a review Clin Exp Ophthalmol, 51 (2023), pp. 484-494, 10.1111/ceo.14214

6 L. Goesmann, N. Refaian, J.J. Bosch, L.M. HeindlCharacterization and quantitation of the tumor microenvironment of uveal melanoma Biology, 12 (2023), 10.3390/biology12050738

7 D.C. Branisteanu, et al.Uveal melanoma diagnosis and current treatment options (Review) Exp Ther Med, 22 (2021), p. 1428, 10.3892/etm.2021.10863

8 N. Refaian, et al.Comparing the hem- and lymphangiogenic profile of conjunctival and uveal melanoma cell lines Invest Ophthalmol Vis Sci, 56 (2015), pp. 5691-5697, 10.1167/iovs.15-16829

9 M.M. Karg, et al.Midkine promotes metastasis and therapeutic resistance via mTOR/RPS6 in uveal melanoma Mol Cancer Res, 20 (2022), pp. 1320-1336, 10.1158/1541-7786.Mcr-20-0692

10 A.D. Singh, A. TophamIncidence of uveal melanoma in the United States: 1973-1997 Ophthalmology, 110 (2003), pp. 956-961, 10.1016/s0161-6420(03)00078-2

11 M.E. Aronow, A.K. Topham, A.D. SinghUveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013) Ocul Oncol Pathol, 4 (2018), pp. 145-151, 10.1159/000480640

12 S. Conte, et al.Uveal melanoma incidence trends in Canada: 1992-2010 vs. 2011-2017 Front Med, 9 (2022), Article 1001799, 10.3389/fmed.2022.1001799

13 F.M. Ghazawi, et al.Uveal melanoma incidence trends in Canada: a national comprehensive population-based study Br J Ophthalmol, 103 (2019), pp. 1872-1876, 10.1136/bjophthalmol-2018-312966

14 S.J. Park, et al.Nationwide incidence of ocular melanoma in South Korea by using the national cancer registry database (1999-2011) Invest Ophthalmol Vis Sci, 56 (2015), pp. 4719-4724, 10.1167/iovs.15-16532

15 A.B. Beasley, D.B. Preen, S. McLenachan, E.S. Gray, F.K. ChenIncidence and mortality of uveal melanoma in Australia (1982-2014) Br J Ophthalmol, 107 (2023), pp. 406-411, 10.1136/bjophthalmol-2021-319700

16 E.A. Holly, D.A. Aston, D.K. Ahn, A.H. SmithIntraocular melanoma linked to occupations and chemical exposures Epidemiology, 7 (1996), pp. 55-61, 10.1097/00001648-199601000-00010

17 T. Behrens, et al.Hormonal exposures and the risk of uveal melanoma Cancer Causes Control, 21 (2010), pp. 1625-1634, 10.1007/s10552-010-9591-9

18 R.N. Carey, et al.Occupational exposure to solar radiation in Australia: who is exposed and what protection do they use? Aust N Z J Publ Health, 38 (2014), pp. 54-59, 10.1111/1753-6405.12174

19 R.N. Carey, et al.Estimated prevalence of exposure to occupational carcinogens in Australia (2011-2012) Occup Environ Med, 71 (2014), pp. 55-62, 10.1136/oemed-2013-101651

20 J.Z. Lim, et al.The burden of histologically confirmed uveal melanoma in aotearoa-New Zealand: a 21-year review of the national cancer registry Asia Pac J Ophthalmol (Phila), 12 (2023), pp. 384-391, 10.1097/apo.0000000000000625

21 G. Virgili, et al.Incidence of uveal melanoma in Europe Ophthalmology, 114 (2007), pp. 2309-2315, 10.1016/j.ophtha.2007.01.032

22 L. Bergman, et al.Incidence of uveal melanoma in Sweden from 1960 to 1998 Invest Ophthalmol Vis Sci, 43 (2002), pp. 2579-2583

23 C.E. Margo, Z. Mulla, K. BillirisIncidence of surgically treated uveal melanoma by race and ethnicity Ophthalmology, 105 (1998), pp. 1087-1090, 10.1016/s0161-6420(98)96012-2

24 S. Mallone, et al.Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe Eur J Cancer, 48 (2012), pp. 1167-1175, 10.1016/j.ejca.2011.10.004

25 V. Gill, et al.Trends in uveal melanoma presentation and survival during five decades: a nationwide survey of 3898 Swedish patients Front Med, 9 (2022), Article 926034, 10.3389/fmed.2022.926034

26 T.D. Keenan, D. Yeates, M.J. GoldacreUveal melanoma in England: trends over time and geographical variation Br J Ophthalmol, 96 (2012), pp. 1415-1419, 10.1136/bjophthalmol-2012-301812

27 A.S. Alfaar, A. Saad, P. Wiedemann, M. RehakThe epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015 Graefes Arch Clin Exp Ophthalmol, 260 (2022), pp. 1723-1731, 10.1007/s00417-021-05317-7

28 M.S. Nowak, B. Romanowska-Dixon, I. Grabska-Liberek, M. ŻurekIncidence and survival of ocular melanoma in national cancer registry of Poland in 2010-2017 Adv Clin Exp Med, 31 (2022), pp. 615-621, 10.17219/acem/146581

29 P. Isager, et al.Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study Ophthalmic Epidemiol, 12 (2005), pp. 223-232, 10.1080/09286580591000836

30 H. Quhill, et al.Incidence and survival of uveal melanoma in Northern Ireland: how incomplete data can skew results in rare cancers Eye (Lond), 37 (2023), pp. 2454-2460, 10.1038/s41433-022-02352-4

31 T. Radivoyevitch, E.C. Zabor, A.D. SinghUveal melanoma: long-term survival PLoS One, 16 (2021), Article e0250939, 10.1371/journal.pone.0250939

32 T.M.L. Tong, et al.Time trends in the treatment and survival of 5036 uveal melanoma patients in The Netherlands over a 30-year period Cancers, 15 (2023), 10.3390/cancers15225419

33 T.E. Robsahm, R.S. Falk, N.A. EideAdditional malignancies and mortality in uveal melanoma: a 20-year follow-up of a Norwegian patient cohort Acta Ophthalmol, 101 (2023), pp. 696-704, 10.1111/aos.15659

34 L. Bergman, et al.Uveal melanoma survival in Sweden from 1960 to 1998 Invest Ophthalmol Vis Sci, 44 (2003), pp. 3282-3287, 10.1167/iovs.03-0081

35 J.M. Burr, E. Mitry, B. Rachet, M.P. ColemanSurvival from uveal melanoma in England and Wales 1986 to 2001 Ophthalmic Epidemiol, 14 (2007), pp. 3-8, 10.1080/09286580600977281

36 A. Jamison, et al.Uveal melanoma-associated survival in Scotland Eye (Lond), 33 (2019), pp. 1699-1706, 10.1038/s41433-019-0622-9

37 A.L. Chew, K. Spilsbury, T.W. IsaacsSurvival from uveal melanoma in Western Australia 1981-2005 Clin Exp Ophthalmol, 43 (2015), pp. 422-428, 10.1111/ceo.12490

38 S.J. Park, C.M. Oh, B. Yeon, H. Cho, K.H. ParkSex disparity in survival of patients with uveal melanoma: better survival rates in women than in men in South Korea Invest Ophthalmol Vis Sci, 58 (2017), pp. 1909-1915, 10.1167/iovs.16-20077

39 S. Frenkel, K. Hendler, J. Pe'erUveal melanoma in Israel in the last two decades: characterization, treatment and prognosis Isr Med Assoc J, 11 (2009), pp. 280-285

40 M.J. Jager, et al.Uveal melanoma Nat Rev Dis Prim, 6 (2020), p. 24, 10.1038/s41572-020-0158-0

41 M. Dogrusöz, M.J. Jager, B. DamatoUveal melanoma treatment and prognostication Asia Pac J Ophthalmol (Phila), 6 (2017), pp. 186-196, 10.22608/apo.201734

42 S. Kaliki, C.L. ShieldsUveal melanoma: relatively rare but deadly cancer Eye (Lond), 31 (2017), pp. 241-257, 10.1038/eye.2016.275

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Global incidence and prevalence of malignant orbital tumors

Personalized treatment approaches in intraocular cancer

A UV-related risk analysis in ophthalmic malignancies: Increased UV exposure may cause ocular malignancies